Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods

All authors declared no competing interests for this work. Data sharing not applicable to this article as no datasets were generated or analysed during the current study.